
Work Here?
DexCare provides a digital platform that helps health systems manage how patients find and access medical care. The platform functions as a coordination engine that matches patient needs with available clinical resources in real-time. It works by analyzing data across various care settings—such as virtual visits, urgent care, or specialist appointments—to direct patients to the most appropriate provider based on their specific requirements and the health system's current capacity. Unlike traditional scheduling tools that simply list available times, DexCare focuses on "patient discovery," which actively balances supply and demand to ensure clinical expertise is used efficiently. This approach has helped health systems increase their acquisition of new patients by 30%. The company’s goal is to modernize the healthcare experience by reducing wait times and ensuring that every patient is matched with the right provider at the right time.
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Series C
Total Funding
$145M
Headquarters
Seattle, Washington
Founded
2021
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$145M
Above
Industry Average
Funded Over
3 Rounds
Industry standards
Remote Work Options
Health IT appointments & hires. Hires, promotions, & accolades. AArete Strengthens Healthcare, Operations and AI Consulting Leadership with Managing Director Promotions AArete, a global management and technology consulting firm, announced the promotions of Diane Body, Emily Dawes, Konrad Siczek and Priya Iragavarapu to managing director, as well as the strategic addition of Scott Zambo as vice president of legal and compliance. These leadership appointments position AArete for continued growth and excellence in client delivery on a global scale. David Delaney, MD, Named President of Drug Knowledge Provider FDB (First Databank) Hearst named David Delaney, MD, president of its Hearst Health portfolio company FDB (First Databank, Inc.), a provider of drug knowledge that helps healthcare professionals make precise medication decisions. The announcement was made by Hearst President and CEO Steven R. Swartz and Hearst Health President Gregory Dorn, MD. Delaney brings more than two decades of experience, including serving as a critical care physician and leading large-scale healthcare technology, clinical content, and decision support businesses across payer and provider markets. DexCare Names Ravi Doddivaripalli as CTO to Scale AI-Powered Navigation Across Health Systems DexCare, Inc., announced that Ravi Doddivaripalli has joined the company as its chief technology officer. Doddivaripalli brings experience scaling SaaS platforms with expertise in AI, real-time data integration, and scalable architecture across healthcare and enterprise environments. Dexcom's Jake Leach Named Chair of AdvaMed's Diabetes Sector AdvaMed, the Medtech Association, announced that Jacob "Jake" Leach, President and Chief Executive Officer at Dexcom, will serve as the next chair of the AdvaMed Diabetes Sector, succeeding Chris Scoggins, Executive Vice President of Diabetes Care at Abbott. The AdvaMed Diabetes Sector represents the world's leading companies producing technology across the spectrum of diabetes care. Altera Digital Health Names Sean Sykes as Executive Vice President for Ventus Altera Digital Health, a global health IT leader, announced that Sean Sykes has joined the company as Executive Vice President for Ventus, Altera's suite of integrated revenue cycle and administrative solutions designed to optimize financial performance and operational efficiency. Sykes brings to the role more than 20 years of experience building and scaling high-performing sales and customer success teams at enterprise technology organizations. OFD Life Sciences Expands Leadership as Demand for Lyophilization Accelerates OFD Life Sciences, a division of Oregon Freeze Dry, announced that Danielle Grosso has joined the organization as the Senior Director of Project Management. She will lead the program delivery and enterprise-wide project management across OFD, supporting the company during a period of continued growth. The Blue Cross Blue Shield Association Announces New Chief Information and Technology Officer The Blue Cross Blue Shield Association (BCBSA) announced that Mouli Venkatesan has been named as its chief information and technology officer. Appointments. ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors ImpediMed, a comapny in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composition, announced the appointment of Erik Anderson to its Board of Directors. Teladoc Health Appoints Michael Smith, Experienced Insurance and Financial Services Executive, to Its Board of Directors Teladoc Health, the global company in virtual care, announced the appointment of Michael Smith to its board of directors. With more than three decades of leadership experience in financial management and strategic transformation, Mr. Smith brings a deep understanding of long-term business sustainability within highly regulated, global markets. He joins the board following the previously announced retirements of Eric Evans and Thomas McKinley and will serve on the board's audit and nominating and corporate governance committees. Ibex Medical Analytics Accelerates Global Momentum in AI-Powered Pathology with Strategic Leadership Transition and Expansion in Biopharma Ibex Medical Analytics (Ibex), the global leader in clinical-grade AI-powered pathology, announced continued commercial momentum and expanding global adoption alongside a leadership transition designed to accelerate the company's next phase of growth. Effective immediately, Yair Heller, formerly Chief Operating Officer, has been appointed Chief Executive Officer, and co-founder Joseph Mossel will lead Ibex's rapidly expanding biopharma division and U.S. clinical growth initiatives. AMA Names Christy Loebach as Chief Financial Officer The American Medical Association (AMA) appointed Christy Loebach, MBA, as its next chief financial officer. Loebach will oversee all financial operations for the nation's largest physician organization where she will guide strategic planning, strengthen financial discipline, and partner with leadership to support the AMA's long-term growth. She will assume this role on March 2, 2026. Nabla Deepens Clinical Leadership with Appointment of Dr. Matt Sakumoto as Chief Clinical Product Officer Nabla, one of the most widely adopted AI assistants in clinical care, announced the appointment of Dr. Matt Sakumoto as Chief Clinical Product Officer. A leading clinical informaticist and practicing physician, Dr. Sakumoto joins Nabla at a pivotal moment in the company's growth, reinforcing its commitment to building AI technology grounded in real-world clinical experience.
Healthtech platform DexCare appoints new chief product officer. DexCare, a Seattle company focused on improving patient navigation for healthcare systems, announced the appointment of Rakshay Jain as its new chief product officer. Jain brings over a decade of healthcare technology and consulting experience to his new role. Formerly of Innovaccer, Jain spent the last two years launching multiple AI copilots and agents designed to accelerate value transformation for healthcare systems. This aligns with DexCare's goal of drastically reducing patient wait times with its connected scheduling technology. The company has grown to serve over 57 million patients across 50 states. As CPO, Jain will oversee DexCare's product and design organization as it enhances the intelligence behind the company's navigation platform. He will collaborate with health systems to develop solutions that maximize clinical capacity and direct patients more effectively.
DexCare, Inc., the market-leading platform for orchestrating patient demand and care access, today announced the appointment of Matthew Blosl as Chief Executive Officer and board member.
Matthew Blosl, CEO at DexCareWhat You Should Know: – DexCare, Inc., the market-leading platform provider for orchestrating patient demand and care access, today announced the appointment of Matthew Blosl as its new Chief Executive Officer and board member. – Blosl takes the helm from Co-Founder Derek Streat, who successfully guided DexCare’s evolution from a spinout to a recognized category leader, facilitating care connections for over five million patients nationwide. Streat will transition to DexCare’s Board of Directors.Blosl Bio/BackgroundBlosl brings over two decades of leadership experience to DexCare, with a strong background in fostering cultures of growth and operational excellence within technology-driven organizations. He is known for building high-performing teams and effectively scaling commercial operations, possessing a proven track record of executing growth strategies that deliver significant customer and enterprise value. Before joining DexCare, Blosl held a senior position at Experity, where he led commercial initiatives that significantly expanded the company’s market presence and were pivotal in establishing Experity’s leadership in the ambulatory electronic medical record market.New Leadership to Drive Next Growth PhaseMatthew Blosl steps into the CEO role tasked with leading DexCare through its next stage of growth and scaling its impact across the healthcare ecosystem. His leadership will focus on accelerating platform innovation, notably incorporating AI-driven capabilities, and deepening market adoption among health systems. DexCare, backed by prominent institutional and strategic capital, already partners with leading U.S
DexCare, Inc. announced the addition of three strategic investors—Community Health Network, Tampa General, and Texas Health Resources—in its Series C funding round led by ICONIQ Growth. These partners join existing investors like Providence and Kaiser Permanente. DexCare's care orchestration platform has surpassed 3 million scheduled visits, helping health systems manage patient demand and resources efficiently amidst labor shortages and rising costs.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Series C
Total Funding
$145M
Headquarters
Seattle, Washington
Founded
2021
Find jobs on Simplify and start your career today